Back

SGLT2 inhibition: the potential to change the heart failure landscape? Q&A.

1 May 2017 (13:35 - 13:40)
Organised by:
Congress Presentation Part of: Heart failure: what is the potential of SGLT2 inhibition? Chronic heart failure Open Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

5 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Doctor S. Williams (Manchester, GB) Doctor J. Day (Luton, GB)
Slides Video
Presentation thumbnail
The ongoing problem of heart failure.
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
The ongoing problem of heart failure - Q&A.
Doctor S. Williams (Manchester, GB) Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
SGLT2 inhibition: the potential to change the heart failure landscape?
Doctor M. Kosiborod (Kansas City, US)
Slides Video
Presentation thumbnail
Summary and close.
Doctor S. Williams (Manchester, GB)
Slides

Access the full session

Session thumbnail
Heart failure: what is the potential of SGLT2 inhibition?

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 13:35 CET
You may be interested in
thumbnail
Webinar
SGLT2 inhibitors across the left ventricular function spectrum
24 September 2024
thumbnail
Congress Presentation
Investigation of biomarker response to SGLT2 Inhibition in heart failure (SiN-HF)
30 August 2025
thumbnail
Congress Presentation
Summary.
29 August 2022
thumbnail
Congress Presentation
SGLT2 inhibitors in heart failure with reduced ejection fraction without diabetes mellitus: why are patients outside the magic circle?
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources